![Chris Huiskamp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Huiskamp
Direttore Finanziario/CFO presso Isarna Therapeutics GmbH
Posizioni attive di Chris Huiskamp
Società | Posizione | Inizio | Fine |
---|---|---|---|
Isarna Therapeutics GmbH
![]() Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Direttore Finanziario/CFO | - | - |
Amministratore Delegato | - | - |
Storia della carriera di Chris Huiskamp
Statistiche
Distribuzione geografica
Germania | 2 |
Posizioni
Chief Executive Officer | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Isarna Therapeutics GmbH
![]() Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
- Borsa valori
- Insiders
- Chris Huiskamp
- Esperienza